Karo Pharma AB Stock
Karo Pharma AB Stock
Karo Pharma AB is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 28 € shows a potential of 414.71% for Karo Pharma AB which would more than double the current price.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Karo Pharma AB | - | - | - | - | - | - | - |
Medivir AB | 6.170% | -10.630% | 4.608% | -63.387% | 3.748% | -70.210% | -86.159% |
Active Biotech AB | -1.620% | 3.922% | -7.940% | -39.180% | 24.080% | -69.490% | -87.251% |
NanoViricides Inc. | -1.940% | 1.980% | -7.207% | -13.445% | 8.995% | -69.472% | -75.418% |
Comments
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $26.00 to $29.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat